BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4025212)

  • 1. The effect of hydroxycamptothecin in the activity of RNA and DNA polymerases prepared from murine hepatoma cells.
    Xu B; Ling YH
    Am J Chin Med; 1985; 13(1-4):23-31. PubMed ID: 4025212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 10-hydroxycamptothecin on nuclear RNA polymerase activity in hepatoma cells in mice].
    Ling YH; Yu WJ; Xu B
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):211-3. PubMed ID: 6239516
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells.
    Ling YH; Xu B
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):546-50. PubMed ID: 8010056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
    Zhang XW; Qing C; Xu B
    Anticancer Drugs; 1999 Jul; 10(6):569-76. PubMed ID: 10885905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin, on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells.
    Ling YH; Perez-Soler R; Tseng MT
    Anticancer Res; 1993; 13(5A):1613-7. PubMed ID: 8239542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids.
    Ono K; Nakane H
    J Biochem; 1990 Oct; 108(4):609-13. PubMed ID: 2292590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of 10-hydroxycamptothecin on adenylate cyclase activity in murine hepatoma cells].
    Ling YH; Yu WJ; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Dec; 3(4):264-6. PubMed ID: 6299062
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhibitory effect of 4-hydroxy-nonenal on DNA-polymerases alpha and beta from rat liver and rapidly dividing Yoshida ascites hepatoma.
    Wawra E; Zollner H; Schaur RJ; Tillian HM; Schauenstein E
    Cell Biochem Funct; 1986 Jan; 4(1):31-6. PubMed ID: 3753664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition of DNA polymerases by 4'-epiadriamycin and 4'-O-tetrahydropyranyladriamycin.
    Tanaka M; Yoshida S; Kimura K
    Gan; 1983 Dec; 74(6):829-36. PubMed ID: 6365674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effect of (S)-10-hydroxycamptothecin on mouse hepatoma BW7756 and its possible mode of action.
    Tsou KC; Xu B; Miller EE; Lo KW
    Anticancer Res; 1981; 1(2):115-9. PubMed ID: 7347154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
    Kawato Y; Aonuma M; Hirota Y; Kuga H; Sato K
    Cancer Res; 1991 Aug; 51(16):4187-91. PubMed ID: 1651156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential inhibition of DNA polymerases alpha, delta, and epsilon from Novikoff hepatoma cells by inhibitors of cell proliferation.
    Fox G; Popanda O; Edler L; Thielmann HW
    J Cancer Res Clin Oncol; 1996; 122(2):78-94. PubMed ID: 8576284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of 10-hydroxycamptothecin on chromatin protein synthesis in murine hepatoma cells].
    Ling YH; Zhao CS; Xu B
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):285-8. PubMed ID: 2954382
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases.
    Ono K; Nakane H; Fukushima M; Chermann JC; Barré-Sinoussi F
    Eur J Biochem; 1990 Jul; 190(3):469-76. PubMed ID: 1695572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of terminal deoxynucleotidyl transferase from leukemic cells by streptolydigin.
    DiCioccio RA; Srivastava BI
    Biochem Biophys Res Commun; 1976 Oct; 72(4):1343-9. PubMed ID: 63283
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between lactone ring forms of HCPT and their antitumor activities.
    Zhou JJ; Liu J; Xu B
    Acta Pharmacol Sin; 2001 Sep; 22(9):827-30. PubMed ID: 11749865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel phenalenone derivatives from a marine-derived fungus exhibit distinct inhibition spectra against eukaryotic DNA polymerases.
    Perpelescu M; Kobayashi J; Furuta M; Ito Y; Izuta S; Takemura M; Suzuki M; Yoshida S
    Biochemistry; 2002 Jun; 41(24):7610-6. PubMed ID: 12056892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of 10-hydroxycamptothecin on cAMP and cGMP levels in hepatoma and liver tissue of mice (author's transl)].
    Yang JL; Han JX; Shen ZM; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):248-52. PubMed ID: 6280444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.